Evidence map›Paper›PMID 42153590›Full record

ArticleClinical transplantation2026

Recommendations for Living Kidney Donor Follow-Up in Canada.

Sunita K Singh, Allison Jaure, Maia P Gill, Olwyn Johnston, Jagbir Gill, Natasha Caton, Michel Pâquet, Peggy John, Angela Ogniben, Sarah Chritchley and 20 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Sunita K SinghAjmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, Canada.
Allison JaureSydney School of Public Health, The University of Sydney, Sydney, Australia.
Maia P GillProvidence Health Care Research Institute, Vancouver, Canada.
Olwyn JohnstonDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, Canada.
Jagbir GillDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, Canada.
Natasha CatonDepartment of Medicine, University of British Columbia, Vancouver, Canada.
Michel PâquetUniversity of Montreal, CHUM, Montreal, Canada.
Peggy JohnCanadian Blood Services, Ottawa, Canada.
Angela OgnibenProvidence Health Care Research Institute, Vancouver, Canada.
Sarah ChritchleyDepartment of Family Practice, University of British Columbia, Vancouver, Canada.
Christine DipchandDivision of Nephrology, Department of Medicine, Dalhousie University, Halifax, Canada.
Justin GillDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, Canada.
Pamela PikeDivision of Nephrology, Department of Medicine, Memorial University, St. John's, Canada.
M Khaled ShamseddinDivision of Nephrology, Department of Medicine, Queen's University, Kingston, Canada.
Jason BauSchool of Medicine, Toronto Metropolitan University, Toronto, Canada.
Sita GourishankarDivision of Nephrology, Department of Medicine, University of Alberta, Edmonton, Canada.
Julie LesageDivision of Nephrology, Department of Medicine, Universite Laval, Quebec, Canada.
Rahul MainraDivision of Nephrology, Department of Medicine, University of Saskatchewan, Saskatoon, Canada.
Seychelle YohannaDivision of Nephrology, Department of Medicine, McMaster University, Hamilton, Canada.
Dervla M ConnaughtonDivision of Nephrology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Canada.
Nessa GoganDivision of Nephrology, Department of Medicine, Dalhousie University, Halifax, Canada.
Leroy StorsleyDivision of Nephrology, Department of Medicine, University of Manitoba, Winnipeg, Canada.
Vanessa ReddittDepartment of Family and Community Medicine, University of Toronto, Toronto, Canada.
Melissa DuffDepartment of Family Practice, University of British Columbia, Vancouver, Canada.
Rosanna CazzolliSydney School of Public Health, The University of Sydney, Sydney, Australia.
Amanda DominelloSydney School of Public Health, The University of Sydney, Sydney, Australia.
Javier Reaburn SilvaSydney School of Public Health, The University of Sydney, Sydney, Australia.
Nicole Scholes-RobertsonSydney School of Public Health, The University of Sydney, Sydney, Australia.
Victoria SinkaSydney School of Public Health, The University of Sydney, Sydney, Australia.
John S GillDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, Canada.

Funding

Canadian Blood Services
6 · The paper itself

Abstract

backgroundPost-donation care is variable in Canada.

methodsA virtual workshop including donors and health providers was conducted to advance recommendations for a new national standard of living donor follow-up. Attendees participated in facilitated breakout groups to deliberate pre-set questions on a draft care model informed by a survey of 685 previous donors. Deliberations were audio-recorded, transcribed, and imported into HyperRESEARCH software to facilitate inductive, systematic and auditable coding of the data. Final meeting recommendations were approved by attendees and then presented for consideration of endorsement by all Canadian programs.

resultsWe identified four themes: (1) Establishing a donor centric long-term follow-up plan; (2) Generating data to optimize donor outcomes; (3) Safeguarding donors and (4) Partnership to strengthen care (transplant centers enacting duty of care, setting expectations with donors for follow up, supporting a collaborative model with primary care doctors, harnessing technology, ensuring consistency, regularity, and feasibility). Post-donation care should be donor-centric, flexible and based on a strong collaboration between primary care providers and transplant programs. The new model should include a "safety net" to provide specialist care when needed, as well as donor consent for capture of long-term health outcomes in a national registry. The recommendations are endorsed by all Canadian living donor programs.

conclusionsAlthough necessary, the provision of universal health care coverage alone is insufficient to ensure long-term donor health and inform future practice. A new national model of long-term donor follow-up informed by the lived experience of past donors and input from primary care and transplant providers was proposed.

Indexed as

AftercareKidney TransplantationLiving DonorsPractice Guidelines as TopicTissue and Organ ProcurementCanadaFollow-Up StudiesHumansdonor outcomesliving kidney donationlong‐term follow‐up

Identifiers

PMID42153590
PMCPMC13185681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.